| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/03/2011 | EP2349333A1 Mimotopes of hiv env |
| 08/03/2011 | EP2349332A2 Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
| 08/03/2011 | EP2349331A2 Humanized anti-il-6 antibodies |
| 08/03/2011 | EP2349330A1 Methods for mediating fibrotic response |
| 08/03/2011 | EP2349329A1 Use of igf-ii/igf-iie binding for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis |
| 08/03/2011 | EP2349327A2 Directed engagement of activating fc receptors |
| 08/03/2011 | EP2349315A1 Regulation of lymphocytes and uses therefor |
| 08/03/2011 | EP1860119B1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 08/03/2011 | EP1692265B1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
| 08/03/2011 | EP1688488B1 Bispecific antibody substituting for factor viii |
| 08/03/2011 | EP1688432B1 Igm high concentration stabilized solution |
| 08/03/2011 | EP1631314B1 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | EP1534752B1 Antibodies that specifically bind to chemokine beta-4 |
| 08/03/2011 | EP0975755B2 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 08/03/2011 | EP0784631B1 Method of producing a partial orf2 protein of hepatitis e virus |
| 08/03/2011 | CN1901937B Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 08/03/2011 | CN1878871B IL-1 receptor based antagonists and methods of making and using |
| 08/03/2011 | CN102143979A Monoclonal antibodies against tissue factor pathway inhibitor (TFPI) |
| 08/03/2011 | CN102143978A Anti- P2X7 peptides and epitopes |
| 08/03/2011 | CN102143977A Multispecific antibodies |
| 08/03/2011 | CN102143976A Stable and soluble antibodies inhibiting VEGF |
| 08/03/2011 | CN102143975A Therapeutic use of specific ligand in MSRV associated diseases |
| 08/03/2011 | CN102143974A Human cytomegalovirus neutralising antibodies and use thereof |
| 08/03/2011 | CN102140139A Antitumor human single-chain antibody |
| 08/03/2011 | CN102140129A Chicken pdx1 polyclonal antibody and application |
| 08/03/2011 | CN102139106A Binding molecules capable of neutralizing rabies virus and uses thereof |
| 08/03/2011 | CN101495632B Humanized anti-human osteopontin antibody |
| 08/02/2011 | US7991601 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 08/02/2011 | US7989598 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates |
| 08/02/2011 | US7989597 Immunogenic memapsin 2 β-secretase peptides and methods of use |
| 08/02/2011 | US7989596 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 08/02/2011 | US7989595 Compositions and methods for the diagnosis and treatment of tumor |
| 08/02/2011 | US7989594 Modified antibody fab fragments |
| 08/02/2011 | US7989590 Peptides that increase collagen or hyaluronic acid production |
| 08/02/2011 | US7989434 Heterocyclic self-immolative linkers and conjugates |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989171 Anti-human tenascin monoclonal antibody |
| 08/02/2011 | US7988979 Neisseria meningitidis antigens and compositions |
| 08/02/2011 | US7988975 Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies |
| 08/02/2011 | US7988972 Immunoreactive peptides from Epstein-Barr virus |
| 08/02/2011 | US7988971 Human monoclonal antibodies against Hendra and Nipah viruses |
| 08/02/2011 | US7988969 Treatment for central nervous system disorders |
| 08/02/2011 | US7988967 High affinity human antibodies to human nerve growth factor |
| 08/02/2011 | US7988966 Method for the potentiation of opioid analgesics effects on pain |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988964 NOGO-a neutralising immunoglobulin for treatment of neurological diseases |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2436623C Branched polyalkylene glycols |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2417255C Medicament comprising amrubicin and an anti-her2 antibody for treating breast cancer |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2329683C Iga nephropathy-related dna |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2320220C Isolated dna or gene responsible for parkinson's disease |
| 08/02/2011 | CA2265498C Staphylococcus aureus antigen |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 08/02/2011 | CA1341619C Recombinant inhibin |
| 07/28/2011 | WO2011091286A1 Compositions and methods for treatment of ovarian cancer |
| 07/28/2011 | WO2011091177A1 Anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 07/28/2011 | WO2011091078A2 Antibody fc variants with enhanced complement activity |
| 07/28/2011 | WO2011090762A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | WO2011090761A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | WO2011090754A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | WO2011090720A2 Purification of proteins |
| 07/28/2011 | WO2011090719A2 Protein purification by ion exchange |
| 07/28/2011 | WO2011090492A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
| 07/28/2011 | WO2011090166A1 Esophageal cancer marker |
| 07/28/2011 | WO2011089212A1 Chromatographic method for purifying fc-containing proteins |
| 07/28/2011 | WO2011089211A1 Anti-cd133 antibodies and methods of using the same |
| 07/28/2011 | WO2011089183A2 Anticoagulant antidotes |
| 07/28/2011 | WO2011089004A1 Cancer stem cell markers and uses thereof |
| 07/28/2011 | WO2011061492A3 Multivalent antibodies |
| 07/28/2011 | WO2011061246A3 Multivalent antibodies |
| 07/28/2011 | WO2011059755A3 Dual variable domain immunoglobulins and uses thereof |
| 07/28/2011 | WO2011053783A3 Ax213 and ax132 pcsk9 antagonists and variants |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184152 Biological Products |
| 07/28/2011 | US20110184151 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| 07/28/2011 | US20110184150 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183893 Non-natural mic proteins |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183863 Protein screening methods |
| 07/28/2011 | US20110183855 Somatic hypermutation systems |
| 07/28/2011 | US20110183412 Alteration of fc-fusion protein serum half-lives by mutagenesis |
| 07/28/2011 | US20110183402 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 07/28/2011 | US20110183363 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
| 07/28/2011 | US20110183360 Antibodies to clostridium difficile spores and uses thereof |
| 07/28/2011 | US20110183336 Method to Predict Responsiveness of Breast Cancer to Polyamine-Type Chemotherapy |
| 07/28/2011 | US20110182940 Method for producing purified influenza virus antigen |
| 07/28/2011 | US20110182928 Vaccine against amyloid folding intermediate |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182919 Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| 07/28/2011 | US20110182917 Therapeutic or prophylactic agent for generalized pain syndrome |
| 07/28/2011 | US20110182916 Use of Agonists of Integrin Alpha 5 for Inducing the Osteogenic Differentiation of Mesenchymal Stem Cells |
| 07/28/2011 | US20110182914 Methods and compositions |
| 07/28/2011 | US20110182907 Anti-alpha-Enolase I Antibodies for Diagnosis and Treatment of alpha-Enolase I-Associated Diseases |